Accelerating Treatments and Biomarkers for Alzheimer’s Disease and Related Disorders

Allan Levey, MD, PhD
Robert W. Woodruff Professor
Director of the Goizueta Alzheimer’s Disease Research Center and the Goizueta Institute
Emory University

Objectives

• Understand the complexity and heterogeneity of molecular changes in ADRD brain
• Learn about the Accelerating Medicine Partnership for Alzheimer’s Disease
• Learn about emerging biomarkers and novel therapeutic targets

Disclosures

• Planners: Bruce L. Miller, MD; Howard J. Rosen, MD; Andrew Breithaupt, MD; and Eleanor O’Brien have stated they have no relationships to disclose.
• Speaker: Allan Levey, MD, PhD, has disclosed the following relationship: EmTheraPro.

Accreditation: The University of California, San Francisco (UCSF) School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation: UCSF designates this live activity for a maximum of 22 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit is inclusive of all Memory and Aging Center Grand Rounds sessions offered from January 1, 2023, through December 31, 2023. (1 credit per each 1-hour grand rounds session throughout the year).

Questions? Email Andrew Breithaupt, MD, at Andrew.Breithaupt@ucsf.edu.

Attendees must register for this event. Grand Rounds presentations are for educational purposes and intended for a professional audience with a terminal degree. This activity is not commercially supported.